{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:02:02Z","timestamp":1785769322494,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8F1091"],"award-info":[{"award-number":["CMRPG8F1091"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.psychres.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T13:52:48Z","timestamp":1523109168000},"page":"412-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Orexin A in men with heroin use disorder undergoing methadone maintenance treatment"],"prefix":"10.1016","volume":"264","author":[{"given":"Meng-Chang","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiao-Lai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.psychres.2018.04.010_bib0001","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/bph.12450","article-title":"The concise guide to pharmacology 2013\/14: transporters","volume":"170","author":"Alexander","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2018.04.010_bib0002","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.conb.2013.04.008","article-title":"Control of arousal by the orexin neurons","volume":"23","author":"Alexandre","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"issue":"3","key":"10.1016\/j.psychres.2018.04.010_bib0003","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1748-1716.2009.02036.x","article-title":"Activation of the basal forebrain by the orexin\/hypocretin neurones","volume":"198","author":"Arrigoni","year":"2010","journal-title":"Acta Physiol."},{"issue":"56 Suppl","key":"10.1016\/j.psychres.2018.04.010_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2008.06.060","article-title":"Role of lateral hypothalamic orexin neurons in reward processing and addiction","volume":"1","author":"Aston-Jones","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2018.04.010_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2017.07.008","article-title":"Inhibition of TrkB at the nucleus accumbens, using ANA-12, regulates basal and stress-induced orexin A expression within the mesolimbic system and affects anxiety, sociability and motivation","volume":"125","author":"Azogu","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0006","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bph.12639","article-title":"Orexin\/hypocretin role in reward: implications for opioid and other addictions","volume":"172","author":"Baimel","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2018.04.010_bib0007","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.celrep.2017.01.030","article-title":"Projection-target-defined effects of orexin and dynorphin on VTA dopamine neurons","volume":"18","author":"Baimel","year":"2017","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.psychres.2018.04.010_bib0008","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/cne.21420","article-title":"Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons","volume":"503","author":"Balcita-Pedicino","year":"2007","journal-title":"J. Comp. Neurol."},{"issue":"6","key":"10.1016\/j.psychres.2018.04.010_bib0009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.alcohol.2011.02.306","article-title":"Orexin A expression and promoter methylation in patients with alcohol dependence comparing acute and protracted withdrawal","volume":"45","author":"Bayerlein","year":"2011","journal-title":"Alcohol"},{"key":"10.1016\/j.psychres.2018.04.010_bib0010","article-title":"Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine","author":"Bernstein","year":"2017","journal-title":"Addict. Biol"},{"key":"10.1016\/j.psychres.2018.04.010_bib0011","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1038\/ncomms7266","article-title":"Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses","volume":"6","author":"Bonnavion","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.psychres.2018.04.010_bib0012","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphys.2017.00357","article-title":"Orexin system: the key for a healthy life","volume":"8","author":"Chieffi","year":"2017","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.psychres.2018.04.010_bib0013","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1038\/s41598-017-08202-8","article-title":"Multiple excitatory actions of orexins upon thalamo-cortical neurons in dorsal lateral geniculate nucleus - implications for vision modulation by arousal","volume":"7","author":"Chrobok","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.psychres.2018.04.010_bib0014","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ijnp\/pyx033","article-title":"Phase II proof-of concept trial of the orexin receptor antagonist filorexant (MK-6096) in patients with major depressive disorder","volume":"20","author":"Connor","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2018.04.010_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2014.06.001","article-title":"Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels","volume":"47","author":"D'Aunno","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.psychres.2018.04.010_bib0016","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.psychres.2018.04.010_bib0017","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1037\/a0013276","article-title":"Steady-state methadone effect on generalized arousal in male and female mice","volume":"122","author":"Devidze","year":"2008","journal-title":"Behav. Neurosci."},{"issue":"14","key":"10.1016\/j.psychres.2018.04.010_bib0018","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0019","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0006-8993(99)01824-7","article-title":"Food intake elicited by central administration of orexins\/hypocretins: identification of hypothalamic sites of action","volume":"842","author":"Dube","year":"1999","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-010-2048-8","article-title":"Hypocretin 1\/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration","volume":"214","author":"Espana","year":"2011","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0021","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espana","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0022","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pbb.2008.01.008","article-title":"Orexin\/hypocretin modulation of the basal forebrain cholinergic system: insights from in vivo microdialysis studies","volume":"90","author":"Fadel","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2018.04.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2017.08.003","article-title":"Role of orexin receptors in the ventral tegmental area on acquisition and expression of morphine-induced conditioned place preference in the rats","author":"Farahimanesh","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psychres.2018.04.010_bib0024","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroscience.2017.02.038","article-title":"Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress","volume":"348","author":"Grafe","year":"2017","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.psychres.2018.04.010_bib0025","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/adb.12236","article-title":"Orexin A-mediated AKT signaling in the dentate gyrus contributes to the acquisition, expression and reinstatement of morphine-induced conditioned place preference","volume":"21","author":"Guo","year":"2016","journal-title":"Addict. Biol."},{"issue":"7058","key":"10.1016\/j.psychres.2018.04.010_bib0026","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.psychres.2018.04.010_bib0027","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbr.2007.05.025","article-title":"Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward","volume":"183","author":"Harris","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.psychres.2018.04.010_bib0028","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0196-9781(99)00105-9","article-title":"Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat","volume":"20","author":"Haynes","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.psychres.2018.04.010_bib0029","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/7854_2016_56","article-title":"Role of the orexin\/hypocretin system in stress-related psychiatric disorders","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.psychres.2018.04.010_bib0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A decade of orexin\/hypocretin and addiction: where are we now?","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2018.04.010_bib0031","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(24)38126-1","article-title":"Orexin A but not orexin B rapidly enters brain from blood by simple diffusion","volume":"289","author":"Kastin","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0032","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/bph.12415","article-title":"The hypocretins\/orexins: integrators of multiple physiological functions","volume":"171","author":"Li","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2018.04.010_bib0033","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/hbeh.2000.1584","article-title":"Differential distribution and regulation of OX1 and OX2 orexin\/hypocretin receptor messenger RNA in the brain upon fasting","volume":"37","author":"Lu","year":"2000","journal-title":"Horm. Behav."},{"issue":"1","key":"10.1016\/j.psychres.2018.04.010_bib0034","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J. Comp. Neurol."},{"issue":"16","key":"10.1016\/j.psychres.2018.04.010_bib0035","doi-asserted-by":"crossref","first-page":"E1648","DOI":"10.1073\/pnas.1315542111","article-title":"Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area","volume":"111","author":"Muschamp","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0036","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1523\/JNEUROSCI.2761-05.2006","article-title":"Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine","volume":"26","author":"Narita","year":"2006","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.psychres.2018.04.010_bib0037","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrn3939","article-title":"The dopamine theory of addiction: 40 years of highs and lows","volume":"16","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"23","key":"10.1016\/j.psychres.2018.04.010_bib0038","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0039","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/add.13193","article-title":"Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England","volume":"111","author":"Pierce","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.psychres.2018.04.010_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopha.2017.03.053","article-title":"A review of the role of orexin system in pain modulation","volume":"90","author":"Razavi","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.psychres.2018.04.010_bib0041","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1523\/JNEUROSCI.3917-11.2012","article-title":"Lateral hypothalamic orexin\/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference","volume":"32","author":"Richardson","year":"2012","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.psychres.2018.04.010_bib0042","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrn3837","article-title":"The role of orexin in motivated behaviours","volume":"15","author":"Sakurai","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.psychres.2018.04.010_bib0043","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1016\/j.orcp.2013.12.001","article-title":"Roles of orexins in the regulation of body weight homeostasis","volume":"8","author":"Sakurai","year":"2014","journal-title":"Obes. Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.psychres.2018.04.010_bib0044","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.psychres.2018.04.010_bib0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0006-8993(99)01136-1","article-title":"Feeding response to central orexins","volume":"821","author":"Sweet","year":"1999","journal-title":"Brain Res."},{"issue":"1-2","key":"10.1016\/j.psychres.2018.04.010_bib0046","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01266-6","article-title":"Distribution of orexin receptor mRNA in the rat brain","volume":"438","author":"Trivedi","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.psychres.2018.04.010_bib0047","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.ps.40.020189.001203","article-title":"Brain dopamine and reward","volume":"40","author":"Wise","year":"1989","journal-title":"Annu. Rev. Psychol."},{"issue":"12","key":"10.1016\/j.psychres.2018.04.010_bib0048","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.cellsig.2013.07.025","article-title":"Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders","volume":"25","author":"Xu","year":"2013","journal-title":"Cell Signal."},{"issue":"3","key":"10.1016\/j.psychres.2018.04.010_bib0049","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.npep.2014.04.003","article-title":"Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine","volume":"48","author":"Zarepour","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psychres.2018.04.010_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/282641","article-title":"Different levels in orexin concentrations and risk factors associated with higher orexin levels: comparison between detoxified opiate and methamphetamine addicts in 5 Chinese cities","volume":"2013","author":"Zhang","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.psychres.2018.04.010_bib0051","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.physbeh.2014.11.002","article-title":"Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats","volume":"139","author":"Zhou","year":"2015","journal-title":"Physiol. Behav."},{"issue":"4","key":"10.1016\/j.psychres.2018.04.010_bib0052","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/alcalc\/agv129","article-title":"Orexin in patients with alcohol dependence treated for relapse prevention: a pilot study","volume":"51","author":"Ziolkowski","year":"2016","journal-title":"Alcohol Alcohol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811731908X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811731908X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:31:01Z","timestamp":1759037461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811731908X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":52,"alternative-id":["S016517811731908X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2018.04.010","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orexin A in men with heroin use disorder undergoing methadone maintenance treatment","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}